Nolato AB ser. B(0OA9)
SEK --+0.00%
Reward52Moderate
Risk21Low
📊50%Data
3.5% dividend yield
0OA9
+0.0 · +0.00%
SEK · LSE
Nolato AB ser. B |
Earnings Deterioration
Market Cap:1.51Bn
ℹ️
Reward Rating
52
Moderate
Bottom 50% (model universe)
50% data coverage
ℹ️
Risk Rating
21
Low
Risk Assessment
ℹ️

Educational tool only – Scores are based on historical data and financial metrics for informational purposes. This is not financial advice or a recommendation to buy or sell any security. Always conduct your own research or consult a qualified financial adviser.

ℹ️ Educational tool only · More
Limited data coverage
We don't have enough public data on 0OA9 to score it reliably yet — Reward, Risk, Forecasts and Dividends tabs aren't available for this stock. The price chart and basic profile are still shown.
OTC / ADR stock — scores and fundamentals use data tagged in USD by our provider. The issuer may report in a different home currency (e.g. JPY), so treat figures as directional rather than precise.
Not available for limited-coverage stocks
The overview tab requires fundamentals and price history we don't have for this stock. The price chart is the most reliable view we have — try the Chart tab.

Market Performance

Stock returned +10.0% over the past year, broadly in line with market conditions.

What is Nolato AB ser. B?

Nolato AB (publ) develops, manufactures, and sells plastic, silicone, and thermoplastic elastomer products in Europe, Asia, North America, and internationally.

0OA9 · Verdict

Moderate reward · low risk

0OA9 stands out on cash flow and balance sheet, but watch the profitability signal.

Based on 75% data coverage

0OA9 · Verdict

What’s working & what to watch

Strengths 3

  • Cash flow95/100

    Top decile vs peers

  • Balance sheet84/100

    Current ratio 1.80

  • Volatility65/100

    Above average

Watchouts 1

  • Profitability33/100

    14% return on equity

Model-based scoring. For information only — not financial advice.

What is Nolato AB ser. B?

Nolato AB (publ) develops, manufactures, and sells plastic, silicone, and thermoplastic elastomer products in Europe, Asia, North America, and internationally. It operates through the Medical Solutions and Engineered Solutions segments. The company is listed on the LSE in UK, with a market capitalisation of 1.51B, and a P/E ratio of 0.1x.

Financial Highlights

Investment Breakdown

📈 Growth
Moderate growth momentum — positive trajectory without breakout acceleration.
💰 Profitability
Thin or inconsistent margins weigh on earnings quality.
⚠️ Risk
Below-average volatility supports a steadier risk profile.
💸 Valuation
Valuation appears fair relative to current fundamentals.

OpenBook Logo Analysis

Reward: Moderate (52)

The scoring profile indicates limited reward potential at this time, with valuation and growth offering the most support. Risk indicators are low, suggesting a relatively contained downside profile.

For informational purposes only. Not financial advice.

Company Information
SectorN/A
Market Cap1.51B
P/E Ratio0.1175
Dividend Yield3.45%
52 Week High64.65
52 Week Low45.82
Last AnnualDecember
IPO DateN/A
IncorporatedUK
Shares Outstanding26M
No. of Employees5,343
IndustryN/A
ExchangeLSE
Beta0.759
CurrencySEK